Ambalal Sarabhai Enterprise Ltd.

Web: ase.life NSE: AMBALALSA BSE: 500009 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

35 3(7%)

Volume

Open

High

Low

VWAP

52 Week High

52 Week Low

Viand Research Rating

Quality Score

00/00

Growth Score

00/00

Valuation Score

00/00

Momentum Score

00/00

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

268

No. of Shares

7.66

P/E

51.34

P/B

11.23

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

21.89

ROCE

Profit Growth

Listing Date

Promoter Holding

31.36%

FII Holding

DII Holding

Price Chart

Price Performance

1 Week0

1 Month0

3 Months0

6 Months0

1 Year0

YTD0

Moving Average

5 Day SMA0

10 Day SMA0

20 Day SMA0

30 Day SMA0

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3
Resistance 2
Resistance 1
Pivot Point
Support 1
Support 2
Support 3

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	Div Yld %
1	SUNPHARMA	4,42,187	1843	2%	14%	2%	9%	39	0	0	0
2	DIVISLAB	1,80,280	6791	2%	6%	4%	1%	65	0	0	0
3	TORNTPHARM	1,53,281	4529	0%	8%	18%	40%	64	0	0	0
4	APOLLOHOSP	1,19,047	8280	3%	7%	12%	17%	58	0	0	0
5	CIPLA	1,14,869	1422	1%	10%	7%	4%	22	0	0	0
6	DRREDDY	1,11,015	1330	0%	1%	7%	7%	20	0	0	0
7	ZYDUSLIFE	1,09,378	1087	6%	16%	15%	17%	20	0	0	0
8	LUPIN	1,04,017	2275	1%	2%	9%	15%	23	0	0	0
9	MANKIND	1,00,482	2434	3%	7%	7%	2%	49	0	0	0
10	MAXHEALTH	96,867	995	7%	1%	15%	14%	0	0	0	0
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 31.36%	(0.01) 31.36%	(0.01) 31.35%	(0.01) 31.35%	(0.01) 31.35%	(0.01) 31.35%	(0.61) 31.35%	(0.01) 30.78%	(0.01) 30.78%	(0.01) 30.78%	(0.01) 30.78%	(0.01) 30.78%	(0.01) 30.77%	(0.01) 30.77%	(0.01) 30.76%	(0.01) 30.76%	(0.01) 30.76%	(0.01) 30.76%
FIIs	(-0.31) 0.00%	(0.01) 0.34%	(0.01) 0.34%	(0.01) 0.38%	(0.41) 0.38%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(-0.11) 0.00%	(0.01) 0.10%	(0.11) 0.10%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%
Public	68.64%	68.29%	68.32%	68.26%	68.18%	68.54%	68.65%	69.22%	69.23%	69.21%	69.23%	69.22%	69.22%	69.23%	69.23%	69.24%	69.24%	69.24%
No. of Shareholders	167,599	168,396	170,015	169,630	170,912	171,221	172,338	169,228	170,079	171,944	175,222	177,743	178,274	179,404	180,199	181,589	181,213	182,946

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	65.49	52	44.45	40.34	64.81	45.97	44.7	40.7	54.35	43.11	40.01	36.1	44.44	35.36	46.84	43.65	54.43	43.1	56.49
Expenses	59.79	47.92	44.09	38.88	59.51	46.67	42.16	40.23	49.7	40.58	39	40.07	41.09	33.79	46.11	42.91	53.09	37.15	46.63
Operating Profit	5.7	4.08	0.36	1.46	5.3	-0.7	2.54	0.47	4.65	2.53	1.01	-3.97	3.35	1.57	0.73	0.74	1.34	5.95	9.86
OPM %	8.7	7.85	0.81	3.62	8.18	-1.52	5.68	1.15	8.56	5.87	2.52	-11	7.54	4.44	1.56	1.7	2.46	13.81	17.45
Other Income	3.02	1.94	1.62	8.36	-5.37	5.76	2.8	2.3	4.79	1.63	2.85	1.37	5.71	3.06	2.38	2.69	8.54	0.65	1.99
Interest	1.42	0.7	0.96	1.01	0.96	1.14	1.22	0.95	0.9	0.99	0.92	0.95	0.99	0.56	0.45	0.43	0.45	0.33	0.34
Depreciation	1.05	0.96	1.06	0.88	1.02	0.99	1.01	0.98	0.25	1.13	1.14	1.05	0.92	0.61	0.62	0.6	0.62	0.58	0.56
Profit before tax	6.25	4.36	-0.04	7.93	-2.05	2.93	3.11	0.84	8.29	2.04	1.8	-4.6	7.15	3.46	2.04	2.4	8.81	5.69	10.95
Tax %	-4	16.51	1300	-3.66	-86.83	23.89	15.76	59.52	-8.69	34.31	40	5.87	20.14	12.72	50	34.17	13.96	38.49	12.97
Net Profit	6.5	3.64	-0.56	8.22	-0.27	2.23	2.62	0.35	9.02	1.33	1.08	-4.87	5.71	3.01	1.02	1.58	7.59	3.5	9.53
EPS in Rs	0.85	0.47	-0.07	1.07	-0.04	0.29	0.34	0.05	1.18	0.17	0.14	-0.64	0.75	0.39	0.13	0.21	0.99	0.46	1.24

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	202	196	173	170	197	163	133	150	125	134	132	124	105	100
Expenses	190	187	167	162	171	165	136	144	137	137	145	129	112	111
Operating Profit	12	9	6	8	25	-2	-3	6	-12	-3	-13	-4	-7	-10
OPM %	6	5	3	5	13	-1	-2	4	-9	-2	-10	-3	-7	-10
Other Income	15	5	10	12	33	40	24	8	25	-2	95	13	2	16
Interest	4	5	6	3	2	3	4	3	3	5	4	10	11	9
Depreciation	4	4	4	3	2	2	3	2	2	4	17	5	3	14
Profit before tax	19	5	7	15	54	33	15	8	8	-14	62	-6	-20	-16
Tax %	4	-2	15	25	13	10	6	48	84	34	22	13	3	11
Net Profit	18	5	6	11	47	29	14	4	1	-18	48	-7	-20	-18
EPS in Rs	2.32	0.64	0.74	1.49	6.16	3.83	1.83	0.55	0.17	-2.38	6.28	-0.87	-2.64	-2.39
Dividend Payout %	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	13	-18	9	6	11	-2	-7	19	-7	5	-75	-8	11	-3
Cash from Investing Activity	-10	13	-5	-17	5	10	17	-9	18	-3	80	10	-1	0
Cash from Financing Activity	-2	-2	-3	9	-19	-6	-14	-6	-2	-6	-3	-1	-8	3
Net Cash Flow	1	-6	1	-2	-3	2	-4	3	8	-4	2	1	2	-1

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	77	77	77	77	77	77	77	77	77	77	77	77	77	77	77	77
Reserves	82	71	63	64	60	54	43	-3	-32	-46	-50	-51	-38	-86	-79	-59
Borrowings	57	47	51	51	46	45	27	28	31	40	43	42	47	46	42	39
Other Liabilities	66	66	79	69	67	70	84	108	111	144	128	93	94	132	128	110
Total Liabilities	281	260	270	260	250	246	231	210	186	214	197	160	180	169	167	167
Fixed Assets	91	87	87	89	88	85	58	57	57	58	59	72	72	91	94	98
CWIP	2	0	0	0	0	4	12	1	0	24	14	3	9	1	0	0
Investments	32	32	32	32	29	32	33	27	18	9	5	5	8	1	1	1
Other Assets	156	141	151	139	133	125	128	125	110	123	119	80	92	76	71	67
Total Assets	281	260	270	260	250	246	231	210	186	214	197	160	180	169	167	167

Delivery

#	Date	30 20% 36	Value (Cr)	Q/T 179	Del 62	Del 0
1	27-May	35	1	109	55	1
2	26-May	32	0	90	60	0
3	25-May	32	0	102	67	0
4	22-May	33	0	87	58	0
5	21-May	33	1	91	54	0
6	20-May	33	0	70	55	0
7	19-May	31	0	119	56	0
8	18-May	31	0	131	65	0
9	15-May	33	0	99	54	0
10	14-May	31	0	113	75	0
11	13-May	31	0	96	61	0
12	12-May	31	0	92	55	0
13	11-May	32	0	61	58	0
14	8-May	33	0	76	59	0
15	7-May	32	0	111	51	0
16	6-May	31	0	107	60	0
17	5-May	31	0	99	69	0
18	4-May	32	0	143	48	0
19	30-Apr	32	0	129	68	0
20	29-Apr	33	0	79	47	0
21	28-Apr	33	0	99	76	0
22	27-Apr	35	0	112	66	0
23	24-Apr	35	1	94	55	1
24	23-Apr	32	0	124	56	0
25	22-Apr	33	0	114	75	0
26	21-Apr	32	0	85	67	0
27	20-Apr	32	0	298	73	0

Daily Market Cap

Date	Total Market Cap	Change	Chg %
28-May	268c	15c	5.71
27-May	254c	54L	0.21
26-May	254c	5c	2.09
25-May	249c	6c	2.32
22-May	255c	4c	1.68
21-May	251c	4c	1.48
20-May	254c	13c	5.40
19-May	241c	0	0
18-May	241c	7c	2.66
15-May	248c	12c	5.20
14-May	236c	77L	0.32
13-May	237c	84L	0.36
12-May	236c	10c	4.21
11-May	246c	84L	0.34
07-May	245c	4c	1.59
06-May	241c	4c	1.44
05-May	245c	9c	3.65
04-May	254c	12c	5.10
30-Apr	242c	5c	2.17
29-Apr	247c	6c	2.27
28-Apr	253c	77L	0.30
24-Apr	254c	5c	2.07
23-Apr	259c	4c	1.65
22-Apr	255c	13c	5.56
21-Apr	241c	19c	7.35
20-Apr	261c	0	0

Stock Checklist

Price is below from 52 week high low average: 60%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView